Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Patient (n = 39) and tumor characteristics, in patients with head and neck tumors treated via carbon ion radiotherapy.

More »

Table 1 Expand

Fig 1.

Oral mucosal dose surface model and corresponding mucositis.

Representative dose distributions (coronal image, palate, and tongue surface) in a patient with malignant melanoma of the right nasal cavity are shown. The location of the acute radiation mucositis (ARM) approximated the high radiation dose area. ARM was classified as grade 2 according to version 4 of the Common Terminology Criteria for Adverse Events (CTCAE)* and as grade 3 (palate) and grade 0 (tongue) according to the Radiation Therapy Oncology Group (RTOG) criteria. RBE, relative biological effectiveness.

More »

Fig 1 Expand

Table 2.

Locations and stages of acute radiation mucositis in patients with head and neck tumors treated via carbon ion radiotherapy.

More »

Table 2 Expand

Fig 2.

Relationship between the maximum point dose in the oral mucosal dose surface model and acute radiation mucositis (ARM) grade (Common Terminology Criteria for Adverse Events [CTCAE] classification).

Maximum doses in the palate (a) and tongue (b) for grade 0–1 and grade 2–3 ARM. Data are presented as mean ± standard deviation. RBE, relative biological effectiveness.

More »

Fig 2 Expand

Fig 3.

Relationship between the maximum point dose in the oral mucosal dose surface model and acute radiation mucositis (ARM) grade (Radiation Therapy Oncology Group [RTOG] classification).

(a) Maximum doses in the palate for grade 0–1 and grade 2–3 ARM. (b) Receiver operating characteristics (ROC) curve for grade 2–3 ARM in the palate (sensitivity, 1.0; specificity, 1.0). (c) Maximum doses in the tongue for grade 0–1 and grade 2–3 ARM. (d) ROC curve for grade 2–3 ARM in the tongue (sensitivity, 0.9; specificity, 0.9). Data are presented as mean ± standard deviation. RBE, relative biological effectiveness.

More »

Fig 3 Expand

Fig 4.

Comparison of a dose-volume histogram of the tongue with acute radiation mucositis (ARM) grade.

ARM was graded according to the Radiation Therapy Oncology Group (RTOG) criteria. Data are presented as mean ± standard error. *p < 0.05. RBE, relative biological effectiveness.

More »

Fig 4 Expand

Fig 5.

Temporal pattern of acute radiation mucositis (ARM) of the palate or tongue.

We assessed the change in ARM over time. The times are indicated as fractions 1 to 16, and 1 or 2 weeks and 1 month post irradiation.

More »

Fig 5 Expand